The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: December 2024

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

9. Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers

  • 1. Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer
  • 2. Neuronal substance P drives metastasis through an extracellular RNA-TLR7 axis
  • 3. Targeting cancer with small-molecule pan-KRAS degraders
  • 4. Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection
  • 5. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer
  • 6. Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations
  • 7. ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer
  • 8. Macrophage-mediated myelin recycling fuels brain cancer malignancy
  • 9. Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers
  • 10. Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
  • 11.
Previous
Next

Sundaram, L., Kumar, A., Zatzman, M. et al. Science. 385 (6713): eadk9217 (2024).
doi: 10.1126/science.adk9217.

Summary and graphical abstract by Alexandra Boitor, EACR Scientific Officer

Summary of the findings

One of the challenges in cancer research is identifying and understanding the diverse molecular features associated with different genetic lesions and gene regulatory changes that drive carcinogenesis and cancer progression. The Cancer Genome Atlas (TCGA) was created to map diverse molecular features associated with malignancy. One method employed to answer this question has been chromatin accessibility mapping using ATAC-seq, which led to the identification of several malignant signatures across 23 primary human cancer types. However, most studies were performed in bulk cancer tissues, so the current landscape of regulatory elements contains information from tumour-associated stromal or immune cells. In this paper, the authors aimed to deconvolute the existent data from TCGA for eight cancer types (74 individual samples) by employing single-cell chromatin accessibility.
.
The authors managed to successfully separate cancer cells, tumour-infiltrating immune cells and stromal cells based on the single-cell chromatin availability data. Furthermore, the authors were able to identify and measure chromatin accessibility differences in immune cell subsets from various cancer types, cis-regulatory differences between distinct subclones in two samples of glioblastoma and identify the most likely cell type of origin for several breast cancer subtypes. The authors also generated neural network models to predict the impact of genetic variation on chromatin accessibility.
.
.Read more in Science

9. Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers

  • 1. Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer
  • 2. Neuronal substance P drives metastasis through an extracellular RNA-TLR7 axis
  • 3. Targeting cancer with small-molecule pan-KRAS degraders
  • 4. Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection
  • 5. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer
  • 6. Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations
  • 7. ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer
  • 8. Macrophage-mediated myelin recycling fuels brain cancer malignancy
  • 9. Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers
  • 10. Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
  • 11.
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

EACR 2026 Congress Travel Grant recipients share their experiences

EACR 2026 Congress Travel Grant recipients share their experiences

August 3, 2026

We met in Budapest, Hungary for the EACR 2026 Congress between 08-11 June 2026. This EACR conference covered a wide array of topics across the spectrum...

“This access gave me a new perspective on how research can be done”- Katarzyna Wierzbicka’s Travel Fellowship

“This access gave me a new perspective on how research can be done”- Katarzyna Wierzbicka’s Travel Fellowship

July 28, 2026

Katarzyna Wierzbicka is a PhD student at IRB Barcelona, Spain who received an EACR Travel Fellowship to visit and work at the Olivia Newton-John Cancer Research...

“The visit represented a complete shift in how I think about research.” – José Antonio Torres Alcaide’s Travel Fellowship

“The visit represented a complete shift in how I think about research.” – José Antonio Torres Alcaide’s Travel Fellowship

July 27, 2026

José Antonio Torres Alcaide is a PhD student at the Spanish National Cancer Research Center (CNIO) who received an EACR Travel Fellowship to visit and work...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

EACR 2026 Congress Travel Grant recipients share their experiences
Career

EACR 2026 Congress Travel Grant recipients share their experiences

August 3, 2026
“This access gave me a new perspective on how research can be done”- Katarzyna Wierzbicka’s Travel Fellowship
Career

“This access gave me a new perspective on how research can be done”- Katarzyna Wierzbicka’s Travel Fellowship

July 28, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR